The U.S. Food and Drug Administration (FDA) announced that it will fast-track review of nine experimental drugs.
Amid the chaos of the Trump administration’s haphazard job cuts and a mass exodus of leadership, the Food and Drug ...
The US Food and Drug Administration has approved another once-a-day pill that works without hormones to treat moderate to ...
FDA announces Atorvastatin recall affecting over 140,000 bottles of cholesterol medication due to failed dissolution specs ...
The U.S. Food and Drug Administration has approved Bayer's drug to ease hot flashes in menopausal women, the German company ...
FDA approves Bayer’s Lynkuet, a first-of-its-kind non-hormonal pill to treat moderate to severe menopausal hot flashes by ...
The winners include a gene therapy for a rare form of deafness, a drug for vaping addiction, and a generic antibiotic.
The Food and Drug Administration is announcing the first round of drugs that will receive drastically expedited reviews at ...
Bayer AG won support from US regulators for a menopause drug that’s expected to hit the market in November under the name of ...
GSK's London-listed shares fell about 2% on Friday after the U.S. Food and Drug Administration approved only one of two ...
Wawa issued a recall for several of its drinks over possible foreign object contamination.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback